Formycon CEO Dr. Carsten Brockmeyer once again honored as one of the world’s most influential people in the medicines industry

Munich – Dr. Carsten Brockmeyer, CEO of the biosimilar company Formycon AG, has again been chosen as one of the world’s top 100 most influential people in the pharmaceutical sector by the trade magazine “The Medicine Maker”. Brockmeyer was also included in the “Medicine Maker Power List” last year. Dr. Brockmeyer is joined on the list by other highly decorated people from the worlds of industry and science, including Nobel Prize winners, CEOs and a host of outstanding scientists from the pharmaceutical sector.

“I’m delighted to once again have been included in this group of outstanding people in the medicines industry. It shows that biosimilars are constantly growing in importance in the world of medicine. This further accolade also bears testimony to the services that the entire Formycon team has been contributing for years,” said Dr. Carsten Brockmeyer.

The Medicine Maker is a trade magazine published in the United Kingdom and which read all over the world. The list is compiled from readers’ nominations and assistance from experts and is based exclusively on services rendered to medicines development. The rankings are determined in three steps. First, the magazine’s readers are asked which people from the pharmaceutical industry they would include on the list. Out of these nominees, the jurors each select their 100 most influential people. These lists are then consolidated into the final document. The list can be viewed here.